Andhra Pradesh, India

Murali Chebrolu

USPTO Granted Patents = 7 



Average Co-Inventor Count = 9.8

ph-index = 3

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Murali Chebrolu: Innovator in Neurological Treatments

Introduction

Murali Chebrolu is a prominent inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurological disorders. With a total of seven patents to his name, Chebrolu's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents, Chebrolu has developed novel heterocyclic derivatives aimed at treating neurological disorders. These compounds are designed to serve as medicaments, particularly for conditions such as Alzheimer's Disease and diabetes. The inventions focus on the inhibition of BACE-1 or BACE-2, which are critical in the progression of these diseases. The pharmaceutical compositions and combinations derived from these compounds hold promise for advancing treatment options.

Career Highlights

Chebrolu is currently associated with Novartis AG, a leading global healthcare company. His role involves extensive research and development in the pharmaceutical sector, where he applies his expertise to innovate new therapeutic solutions. His work has garnered attention for its scientific rigor and potential clinical applications.

Collaborations

Some of his notable coworkers include Sangamesh Badiger and Konstanze Hurth. Their collaborative efforts contribute to the advancement of research and development in the field of pharmaceuticals.

Conclusion

Murali Chebrolu's contributions to the field of neurological treatments through his innovative patents highlight his role as a key figure in pharmaceutical research. His work continues to pave the way for new therapeutic options that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…